Nutex Health Reports Strong Q1 EPS & Cash Flow, Net Income Up 120% Despite Revenue Miss

summarizeSummary

Nutex Health reported Q1 2026 results with a 120.6% surge in net income and strong operating cash flow, driven by reduced stock-based compensation, despite a modest 2.2% revenue increase that reportedly missed analyst estimates and a 21% decline in Adjusted EBITDA.

check_boxKey Events

• Net Income and EPS Surge

  Net income attributable to Nutex Health increased 120.6% to $46.8 million, with diluted EPS rising 95.8% to $6.52 per share, largely due to a significant reduction in stock-based compensation.

• Revenue Misses Expectations

  Total revenue grew 2.2% to $216.5 million but reportedly fell short of analyst estimates, contributing to a 'mixed' overall performance.

• Strong Operating Cash Flow

  Net cash provided by operating activities increased to $75.5 million for the quarter, up from $51.0 million in the prior year period.

• Adjusted EBITDA Decline

  Adjusted EBITDA attributable to Nutex Health decreased to $57.6 million from $72.8 million in Q1 2025, contrasting with the strong GAAP net income.

auto_awesomeAnalysis

Nutex Health Inc. announced mixed first-quarter 2026 financial results. While total revenue increased modestly by 2.2% to $216.5 million, it reportedly fell short of analyst expectations. However, the company delivered a significant increase in net income attributable to Nutex Health, which surged 120.6% to $46.8 million, resulting in diluted EPS of $6.52, a 95.8% increase. This strong bottom-line performance was notably influenced by a substantial reduction in stock-based compensation expense, which shifted from a $27.6 million expense in Q1 2025 to a $(3.9) million benefit in Q1 2026. Operating cash flow also saw robust growth, increasing to $75.5 million. Conversely, Adjusted EBITDA attributable to Nutex Health declined by 21% to $57.6 million. The company maintains a strong balance sheet with a record cash balance of $207.3 million and reduced long-term debt. Management expressed confidence in planned growth, targeting three new hospital openings and selective self-development of facilities.